Regeneron, Sanofi Skin Cancer Drug Gets Warm Reception from European Regulators

Date : 26/04/2019 @ 18h48
Source : Dow Jones News
Valeur : Sanofi (SNY)
Cours : 46.17  -0.33 (-0.71%) @ 23h14
Sanofi Cours Graphique
After Hours
Last Trade
Last $ 46,17 ◊ 0,00 (0,00%)

Regeneron, Sanofi Skin Cancer Drug Gets Warm Reception from European Regulators

Regeneron Pharmaceuticals (NASDAQ:REGN)
Graphique Historique de l'Action

6 Mois : De Avr 2019 à Oct 2019

Plus de graphiques de la Bourse Regeneron Pharmaceuticals

By Kimberly Chin

 

Regeneron Pharmaceuticals Inc. (REGN) and Sanofi SA (SAN.FR) said a European regulatory panel had issued a positive opinion and recommended conditional approval for their drug that treats patients with a common type of skin cancer.

If the drug, Libtayo, wins approval from the European Commission, it would be the first and only treatment for some patients with an advanced form of carcinoma in Europe.

Libtayo, which is jointly developed by Regeneron and Paris-based Sanofi, is a prescription medicine that treats carcinoma patients with who cannot be cured by surgery or radiation.

The companies said they will need to provide regulators with additional data from a new group trial to help confirm the benefits and risk profile of the drug.

European regulators could make a final decision on Libtayo within the coming months, the companies said.

Shares of Regeneron were down 2.5%, while shares of Sanofi rose 3.5% on Friday.

 

Write to Kimberly Chin at kimberly.chin@wsj.com

 

(END) Dow Jones Newswires

April 26, 2019 12:33 ET (16:33 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Dernières Valeurs Consultées
EU
GLE
Société Gé..
EU
ALU
ALCATEL-LU..
EU
PX1
CAC 40
ORA
Orange
FX
EURUSD
Euro vs Do..
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.


Inscrivez-vous maintenant pour créer votre liste d'actions personnalisée, en streaming.

Les cours EURONEXT (CAC 40, etc. ) et FOREX (les devises) sont en direct si connecté.
NYSE, AMEX, et ASX sont en différé d'environ 20 minutes. Les autres cours sont en différé d'environ 15 minutes.

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V:fr D:20191019 04:36:16